Thomas Perone
Oficial de Cumplimiento en OVID THERAPEUTICS INC. .
Fortuna: 39 603 $ al 31/05/2024
Cargos activos de Thomas Perone
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| OVID THERAPEUTICS INC. | Oficial de Cumplimiento | - | - |
| Consejero General | 21/03/2019 | - | |
| Secretario Corporativo | 21/03/2019 | - |
Historial de carrera de Thomas Perone
Antiguos cargos conocidos de Thomas Perone.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CELGENE | Consejero General | 01/04/2006 | - |
| Secretario Corporativo | 01/06/2014 | 01/05/2018 | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Consejero General | 01/12/2001 | 01/04/2006 |
| Proskauer Rose LLC | Corporate Officer/Principal | - | - |
Formación de Thomas Perone.
| Rutgers State University of New Jersey | Undergraduate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
| Seton Hall University School of Law | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
| Francia | 2 |
Operativa
| General Counsel | 3 |
| Corporate Secretary | 2 |
| Compliance Officer | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| OVID THERAPEUTICS INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
| Proskauer Rose LLC |
- Bolsa de valores
- Insiders
- Thomas Perone
- Experiencia
